AXSM   $95.83  1.60% Market Closed After Close 96.2875 0.48%

Axsome Therapeutics Inc
Total Cash 315.66M
totalCashPerShare 6.576
EBITDA -261.38M
Total Debt 191.80M
quickRatio 2.337
currentRatio 2.482
Total Revenue 291.49M
debtToEquity 186.482
Revenue/Share 6.154
ROA -0.2823
ROE -1.61691
grossProfits
freeCashflow -77.13M
operatingCashflow -167.49M
earningsGrowth
revenueGrowth 0.867
grossMargins 0.90304
ebitdaMargins -0.89671
operatingMargins -0.87059
profitMargins -1.05854
enterpriseValue 4.37B
forwardPE -47.54822
floatShares 35.77M
sharesOutstanding 48.00M
sharesShort 7.61M
sharesShortPriorMonth 8.14M
dateShortInterest
sharesPercentSharesOut 0.16%
heldPercentInsiders 0.17%
heldPercentInstitutions 0.86%
Short Ratio help_outline 17.38%
shortPercentOfFloat 0.19%
impliedSharesOutstanding
bookValue 2.152
Price To Book help_outline 43.53
earningsQuarterlyGrowth
netIncomeToCommon -308.55M
trailingEps -6.58%
forwardEps -1.97%
enterpriseToEbitda -16.73
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.33 3Q 2024
institutionsCount 350
lastUpdated Sept. 16, 2024, 2:58 p.m.